The Raf Inhibitor BAY 43-9006 (Sorafenib) Induces Caspase-Independent Apoptosis in Melanoma Cells

David J. Panka, Wei Wang, Michael B. Atkins, James W. Mier

Open source

DOI
10.1158/0008-5472.can-05-0808
Published
2006-02-01
Container
Cancer Research
Publisher
American Association for Cancer Research (AACR)
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/0008-5472.can-05-0808,
  title = {The Raf Inhibitor BAY 43-9006 (Sorafenib) Induces Caspase-Independent Apoptosis in Melanoma Cells},
  author = {David J. Panka and Wei Wang and Michael B. Atkins and James W. Mier},
  year = {2006},
  journal = {Cancer Research},
  doi = {10.1158/0008-5472.can-05-0808},
  url = {https://doi.org/10.1158/0008-5472.can-05-0808}
}

RIS

TY  - JOUR
TI  - The Raf Inhibitor BAY 43-9006 (Sorafenib) Induces Caspase-Independent Apoptosis in Melanoma Cells
AU  - David J. Panka
AU  - Wei Wang
AU  - Michael B. Atkins
AU  - James W. Mier
PY  - 2006
JO  - Cancer Research
DO  - 10.1158/0008-5472.can-05-0808
UR  - https://doi.org/10.1158/0008-5472.can-05-0808
ER  - 

APA

Panka, D. J., Wang, W., Atkins, M. B., & Mier, J. W. (2006). The Raf Inhibitor BAY 43-9006 (Sorafenib) Induces Caspase-Independent Apoptosis in Melanoma Cells. Cancer Research. https://doi.org/10.1158/0008-5472.can-05-0808

Source records